Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros











Base de dados
Tipo de estudo
Intervalo de ano de publicação
1.
Mol Cell Endocrinol ; 558: 111748, 2022 12 01.
Artigo em Inglês | MEDLINE | ID: mdl-35995307

RESUMO

Thyroid peroxidase (TPO) is a membrane-bound glycoprotein located at the apical side of the thyroid follicular cells that catalyzes both iodination and coupling of iodotyrosine residues within the thyroglobulin molecule, leading to the synthesis of thyroid hormone. Variants in TPO cause congenital hypothyroidism (CH) by iodide organification defect and are commonly inherited in an autosomal recessive fashion. In the present work, we report a detailed population analysis and bioinformatic prediction of the TPO variants indexed in the Genome Aggregation Database (gnomAD) v2.1.1. The proportion of missense cysteine variants and nonsense, frameshift, and splice acceptor/donor variants were analyzed in each ethnic group (European (Non-Finnish), European (Finnish), African/African Americans, Latino/Admixed American, East Asian, South Asian, Ashkenazi Jewish, Other). The results showed a clear predominance of frameshift variants in the East Asian (82%) and European (Finnish) (75%) population, whereas the splice site variants predominate in African/African Americans (99.46%), Other (96%), Latino/Admixed American (94%), South Asian (86%), European (Non-Finnish) (56%) and Ashkenazi Jewish (56%) populations. The analysis of the distribution of the variants indexed in gnomAD v2.1.1 database revealed that most missense variants identified in the An peroxidase domain map in exon 8, followed by exons 11, 7 and 9, and finally in descending order by exons 10, 6, 12 and 5. In total, 183 novel TPO variants were described (13 missense cysteine's variants, 158 missense variants involving the An peroxidase domain and 12 splicing acceptor or donor sites variants) which were not reported in the literature and that would have deleterious effects on prediction programs. In the gnomAD v2.1.1 population, the estimated prevalence of heterozygous carriers of the potentially damaging variants was 1:77. In conclusion, we provide an updated and curated reference source of new TPO variants for application in clinical diagnosis and genetic counseling. Also, this work contributes to elucidating the molecular basis of CH associated with TPO defects.


Assuntos
Hipotireoidismo Congênito , Tireoglobulina , Humanos , Tireoglobulina/genética , Iodeto Peroxidase/genética , Monoiodotirosina/genética , Iodetos , Biologia Computacional , Cisteína , Hipotireoidismo Congênito/genética , Hormônios Tireóideos , Mutação/genética , Peroxidases/genética , Algoritmos
2.
Horm Metab Res ; 22(2): 80-4, 1990 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-2323731

RESUMO

Monoamines are able to increase the thyroid iodine organification in vitro. A predominance of the A form of monoamine oxidase (MAO) has been previously demonstrated to exist in bovine thyroid tissue. In the present study we have investigated the form of MAO that could be involved in the iodotyrosine formation induced by tyramine, 5-hydroxytryptamine (5-HT) and beta-phenylethylamine (PEA) in a bovine thyroid subcellular fraction. The relative capacity of these monoamines to generate H2O2 and to incorporate iodine into tyrosine has also been studied. The MAO A inhibitor clorgyline (10(-9) M) produced a strong inhibition on the iodotyrosine formation induced by tyramine, 5-HT and PEA. In contrast, only a slight reduction was observed with deprenyl as MAO B inhibitor. Among the three monoamines, tyramine produced the highest H2O2 generation and iodotyrosine formation. The lowest Km value obtained was for 5-HT and the highest for PEA. Regarding the Vmax, the lowest value was for 5-HT and the highest for tyramine. The amount of iodine incorporated to tyrosine was not equivalent to the H2O2 generated by the monoamines nor to that exogenously added. Our results indicate that in bovine thyroid tissue mainly the A form of MAO is involved in the monoamine metabolism.


Assuntos
Monoaminoxidase/metabolismo , Monoiodotirosina/biossíntese , Fenetilaminas/farmacologia , Serotonina/farmacologia , Glândula Tireoide/metabolismo , Tiramina/farmacologia , Animais , Bovinos , Clorgilina/farmacologia , Peróxido de Hidrogênio/metabolismo , Iodo/metabolismo , Inibidores da Monoaminoxidase/farmacologia , Monoiodotirosina/antagonistas & inibidores , Especificidade por Substrato , Glândula Tireoide/enzimologia
3.
J Immunoassay ; 10(1): 37-56, 1989.
Artigo em Inglês | MEDLINE | ID: mdl-2715346

RESUMO

125I-labeled human growth hormone (125I-labeled.hGH) was prepared by using two variants of the chloramine T labelling procedure and purified by polyacrylamide gel electrophoresis (PAGE) of the reaction mixture. Variant A produced a tracer with high specific activity (100 +/- 10 microCi/microgram), high maximal binding capacity to antibodies (93%) and long-term stability (at least 150 days at -20 degrees C). No diiodinated tyrosil residues could be detected in this tracer. Variant B was devised to obtain higher yields of labeled hormone. The electrophoresis of the iodination mixture revealed two radioactive components with Rm values of 0.49 and 0.55 which result from the iodination of hGH variants preexisting in the starting material. Both tracers had similar specific activities (70 +/- 10 microCi/microgram), high maximal binding capacity to antibodies or receptors (80-100%, after 80 days of their obtention) and high stability (at least 100 days at -20 degrees C). It is concluded that the iododerivatives of hGH obtained by either method are adequate to perform radioimmunoassay and receptor studies and have long-term stability.


Assuntos
Hormônio do Crescimento/isolamento & purificação , Compostos de Tosil , Cloraminas , Di-Iodotirosina/análise , Estabilidade de Medicamentos , Eletroforese em Gel de Poliacrilamida , Hormônio do Crescimento/metabolismo , Humanos , Técnicas In Vitro , Radioisótopos do Iodo , Monoiodotirosina/análise , Radioimunoensaio , Ensaio Radioligante
4.
J Clin Endocrinol Metab ; 56(4): 767-73, 1983 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-6187759

RESUMO

A specific, sensitive, and reproducible in vitro assay for antithyroid compounds and environmental goitrogens has been used to investigate antithyroid activity (AA) in small samples of water supplying 15 localities in endemic and nonendemic goiter areas of western Colombia. A significant positive correlation was observed between goiter prevalence and AA in water collected from the pipelines of these localities. Samples at the water source showed only borderline significance. No significant correlation was observed in waters between AA and total hardness (ppm) or concentrations of Ca, Mg, sulfates, chlorides, silicates, nitrates, and iodine. AA was also demonstrated by this in vitro assay in well water previously shown experimentally to be goitrogenic and that supplied the endemic goiter district of Candelaria town in western Colombia. In contrast, water from the well supplying the area of lower endemicity was found to possess little AA. These results provide experimental support for epidemiological observations that demonstrate a relationship between the sources of drinking water and goiter prevalence rates, and are consistent with previous findings indicating that organic antithyroid compounds contaminate water supplies in areas where goiter persists despite adequate iodine supplementation.


Assuntos
Antitireóideos/farmacologia , Glândula Tireoide/efeitos dos fármacos , Poluentes Químicos da Água/efeitos adversos , Poluentes da Água/efeitos adversos , Abastecimento de Água , Animais , Bioensaio , Colômbia , Di-Iodotirosina/metabolismo , Bócio Endêmico/induzido quimicamente , Radioisótopos do Iodo/metabolismo , Monoiodotirosina/metabolismo , Suínos , Glândula Tireoide/metabolismo , Hormônios Tireóideos/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA